Format

Send to

Choose Destination
Invest New Drugs. 2019 Aug;37(4):779-783. doi: 10.1007/s10637-019-00726-2. Epub 2019 Jan 10.

Inhibition of AKT signalling by benzoxazine derivative LTUR6 through the modulation of downstream kinases.

Author information

1
Faculty of Science Technology and Engineering, School of Pharmacy and Applied Science, Latrobe Institute of Molecular Sciences, La Trobe University, Bendigo, Australia. rejitha.suraj@ucalgary.ca.
2
Hotchkiss Brain Institute and Libin Cardiovascular Institute of Alberta, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada. rejitha.suraj@ucalgary.ca.
3
College of Science, Health and Engineering, La Trobe University, Bendigo, Australia.
4
Faculty of Science Technology and Engineering, School of Pharmacy and Applied Science, Latrobe Institute of Molecular Sciences, La Trobe University, Bendigo, Australia.

Abstract

Many compounds structurally similar to chromones have been developed to enhance the sensitizing effect of cancer cells to chemotherapeutic agents. Most of these compounds have been shown to promote this sensitization by targeting the repair pathways. One such compound is LTUR6, which enhances the sensitization of doxorubicin to colon cancer cells HT29, by inhibiting the phosphorylation of the double stranded break (DSB) repair enzyme AKT. The downstream regulatory targets of AKT that enhance doxorubicin mediated cytotoxicity in the presence of LTUR6 remains elusive. In this study, we performed comparative analyses of 43 kinase phosphorylation sites using the human phospho-kinase array proteome profiler. Results revealed altered expression levels of multiple proteins that regulated apoptotic signalling pathways. Increased activation of mTOR, RSK1/2/3, p38α and PRAS40 after combination treatment with LTUR6 and doxorubicin over doxorubicin alone was observed. This study provides a deeper insight into the key proteins involved and presents a novel molecular pathway.

KEYWORDS:

AKT; Apoptosis; Chemosensitization; Doxorubicin

PMID:
30627877
DOI:
10.1007/s10637-019-00726-2

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center